(Q37835699)

24 August 2017

1 reference

title

Hepatitis in 2010: the dawn of a new era in HCV therapy (English)

1 reference

24 August 2017

1

Sandra Ciesek

1 reference

24 August 2017

2

Michael P Manns

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

Nature Reviews Gastroenterology & Hepatology

24 August 2017

published in

1 reference

24 August 2017

volume

8

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

69-71

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2010.219

24 August 2017

exact match

0 references

cites work

The way forward in HCV treatment--finding the right path

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.219

Telaprevir for previously treated chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.219

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.219

Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.219

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.219

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.219

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.219

Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.219

10.1038/NRGASTRO.2010.219

31 March 2020

Identifiers

DOI

1 reference

24 August 2017

1 reference